Patents by Inventor Douglas Matthew Anderson

Douglas Matthew Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas Fusion Protein and Methods of Treatment
    Publication number: 20240181084
    Abstract: The present disclosure provides proteins, nucleic acids, systems and methods for editing genomic material and method of treatment.
    Type: Application
    Filed: April 22, 2022
    Publication date: June 6, 2024
    Inventor: Douglas Matthew Anderson
  • Targeted RNA cleavage with dCas13-RNase Fusion Proteins
    Publication number: 20230348871
    Abstract: The present invention provides proteins, nucleic acids, systems and methods for modulating RNA. In some embodiments, the proteins, nucleic acids, systems and methods are used for targeted RNA cleavage. In other embodiments, the proteins, nucleic acids, systems and methods are used for trans-splicing of RNA molecules.
    Type: Application
    Filed: July 15, 2021
    Publication date: November 2, 2023
    Inventor: Douglas Matthew Anderson
  • CRISPR-Cas13 crRNA Arrays
    Publication number: 20230103771
    Abstract: The disclosure provides tandem arrays of CRISPR RNAs and methods of use.
    Type: Application
    Filed: March 26, 2021
    Publication date: April 6, 2023
    Inventor: Douglas Matthew Anderson
  • Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis
    Publication number: 20230078498
    Abstract: The present disclosure provides proteins, nucleic acids, systems and methods for enhancing the synthesis of a protein.
    Type: Application
    Filed: February 5, 2021
    Publication date: March 16, 2023
    Inventor: Douglas Matthew Anderson
  • Ribozyme-mediated RNA Assembly and Expression
    Publication number: 20230073250
    Abstract: The present invention provides compositions, systems and methods for using ribozyme-mediated cis-cleavage and trans-splicing of RNA molecules to express proteins or fusion proteins of interest.
    Type: Application
    Filed: February 5, 2021
    Publication date: March 9, 2023
    Inventor: Douglas Matthew Anderson
  • Targeted RNA cleavage with CRISPR-Cas
    Publication number: 20220267773
    Abstract: The present invention provides proteins, nucleic acids, systems and methods for modulating RNA.
    Type: Application
    Filed: July 23, 2020
    Publication date: August 25, 2022
    Inventor: Douglas Matthew Anderson
  • Targeted Nuclear RNA Cleavage and Polyadenylation with CRISPR-Cas
    Publication number: 20220090088
    Abstract: The present invention provides proteins, nucleic acids, systems and methods for visualizing or modulating RNA.
    Type: Application
    Filed: January 14, 2020
    Publication date: March 24, 2022
    Inventor: Douglas Matthew Anderson
  • Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
    Publication number: 20210363509
    Abstract: The present invention provides proteins, nucleic acids, systems and methods for editing genomic material.
    Type: Application
    Filed: October 22, 2019
    Publication date: November 25, 2021
    Inventor: Douglas Matthew Anderson
  • Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
    Publication number: 20210340508
    Abstract: The present invention provides proteins, nucleic acids, systems and methods for editing genomic material.
    Type: Application
    Filed: July 2, 2021
    Publication date: November 4, 2021
    Inventor: Douglas Matthew Anderson